ORKA
Oruka Therapeutics
ORKA
ORKA
26 hedge funds and large institutions have $5.02M invested in Oruka Therapeutics in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
18% less capital invested
Capital invested by funds: $6.09M → $5.02M (-$1.07M)
31% less call options, than puts
Call options by funds: $148K | Put options by funds: $213K
Holders
26
Holding in Top 10
–
Calls
$148K
Puts
$213K
Top Buyers
| 1 | +$50.5K | |
| 2 | +$43.3K | |
| 3 | +$32.9K | |
| 4 |
HF
HRT Financial
New York
|
+$31.6K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.1K |
Top Sellers
| 1 | -$332K | |
| 2 | -$40.7K | |
| 3 | -$34.5K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$53 |